9,10 Additionally, GLP-1 RAs suppress glucagon secretion from the -cells in the pancreas, leading to decreased blood glucose levels
Anecdotally reported by users to improve sleep quality and recovery, consistent with growth hormone's established role in promoting slow-wave sleep, though this specific outcome has not been directly tested in CJC-1295 clinical trials
GLP-1 RA-experienced patients switching to once-weekly semaglutide in a real-world setting (EXPERT Study)
Semaglutide 2.4 mg (Wegovy) is recommended by NICE (TA875) for eligible adults within specialist weight management services, and tirzepatide (Zepbound) has also received MHRA approval for weight management
They are also at greater risk of muscle loss during weight loss, which has more severe consequences for mobility, bone health, and independence than it does for younger populations